ZNF7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62447832963153E-12 |
Normal-vs-Stage2 |
2.477100000009E-06 |
Normal-vs-Stage3 |
1.35769950837528E-10 |
Normal-vs-Stage4 |
5.93370019785766E-10 |
Stage1-vs-Stage2 |
9.069600E-01 |
Stage1-vs-Stage3 |
8.302200E-01 |
Stage1-vs-Stage4 |
3.907800E-01 |
Stage2-vs-Stage3 |
9.719200E-01 |
Stage2-vs-Stage4 |
6.174800E-01 |
Stage3-vs-Stage4 |
5.760000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
4.9005000057889E-09 |
Normal-vs-Asian |
5.395200E-03 |
Caucasian-vs-AfricanAmerican |
3.578200E-01 |
Caucasian-vs-Asian |
3.784200E-03 |
AfricanAmerican-vs-Asian |
1.539970E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62470037423645E-12 |
Normal-vs-Female |
1.62436730732907E-12 |
Male-vs-Female |
1.406180E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.581200E-03 |
Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(61-80Yrs) |
8.88178419700125E-16 |
Normal-vs-Age(81-100Yrs) |
8.231800E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.042000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.082600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.542800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.540800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.719800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.330200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.63524749297039E-12 |
Normal-vs-Grade 2 |
<1E-12 |
Normal-vs-Grade 3 |
1.73294711913741E-12 |
Normal-vs-Grade 4 |
9.8746999999122E-07 |
Grade 1-vs-Grade 2 |
2.128200E-02 |
Grade 1-vs-Grade 3 |
1.644520E-03 |
Grade 1-vs-Grade 4 |
3.422400E-03 |
Grade 2-vs-Grade 3 |
7.425500E-02 |
Grade 2-vs-Grade 4 |
4.140400E-01 |
Grade 3-vs-Grade 4 |
7.271000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.11022302462516E-16 |
Normal-vs-ccB subtype |
1.05019992702182E-10 |
ccA subtype-vs-ccB subtype |
6.207800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62470037423645E-12 |
Normal-vs-N1 |
2.594300E-02 |
N0-vs-N1 |
6.963400E-01 |
|
|